Should You Buy Reckitt Benckiser Group plc, Smith & Nephew plc And Experian plc Today?

Bilaal Mohamed asks whether or not it would be wise to invest in Reckitt Benckiser Group plc (LON: RB), Smith & Nephew plc (LON: SN) and Experian plc (LON: EXPN).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’ll be taking a closer look at household cleaning products specialist Reckitt Benckiser (LSE: RB), medical equipment manufacturing company Smith & Nephew (LSE: SN) and global information services supplier Experian (LSE: EXPN). Would it be (Motley) Foolish or truly foolish to invest in any of these right now?

Defensive rock

As the world’s largest producer of household goods and cleaning products, Reckitt Benckiser has enjoyed solid growth over the last few years. This is a low-risk defensive company that produces everyday items and well-known brands that are considered essentials in the developed world.

So the company has had a glorious past, but what about the future? City analysts are predicting continuing growth with a 4% rise in earnings this year, and a further 8% rise in 2017. In addition, the company is paying out a modest dividend, with 140.12p per share forecast for this year, rising to 150.56p next year, offering prospective yields of 2.1% and 2.2% over the next couple of years.

Reckitt trades on 25 times forecast earnings for the current year, falling to 23 for the year ending 31 December 2017. Although this may seem a little high, it’s in line with historical levels, and factors-in long-term growth. This is a solid, defensive stock with steady growth and a reasonable dividend. Investors with a long-term view might want to buy on the dips, or drip-feed into the stock.

Temporary halt

After single-digit growth every year for five years, shares in medical equipment firm Smith & Nephew have gone flat, trading in a tight range between 1,051p and 1,212p per share over the past 12 months. This reflects the consensus forecasts that suggest there will be little or no earnings growth this year, followed by a very promising 2017 when a 12% rise in earnings is expected.

What about dividends? As with Reckitt Benckiser, the company pays a moderate dividend, forecast at 22.14p per share for this year, increasing slightly to 24.77p in 2017, offering prospective yields of 2% and 2.2% over the next two years, respectively.

Smith & Nephew trades on 19 times forecast earnings for the current year, falling to 17 for the year ending 31 December 2017. The shares look fully-priced to me, given the average P/E ratio and slow historical growth, and I see no reason for a rerating any time soon.

Brief hiccup

Business services firm Experian issued a solid trading statement in January, reporting a 6% rise in organic growth in the third quarter. However, full-year results to 31 March 2016 are expected to reveal a 10% drop in earnings compared to fiscal 2015 on the back of foreign exchange headwinds.

After five straight years of growth, this should be a temporary blip, as brokers in the Square Mile are predicting a 7% rise next year, and a further 9% rise in 2018.

Experian currently trades on 20 times forecast earnings for this year, falling to 19 next year, then 18 in 2018. The P/E ratio is on a par with firm’s historical levels, and the shares look fully-valued.

Time to buy?

In my opinion, Reckitt Benckiser offers steady growth and a modest dividend for those seeking a low-risk defensive stock, however I can’t see any attractions for buying into Smith & Nephew or Experian at the present time.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Bilaal Mohamed has no position in any shares mentioned. The Motley Fool UK has recommended Reckitt Benckiser. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »